Your browser doesn't support javascript.
loading
FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study.
Köhne, C-H; Poston, G; Folprecht, G; Ciardiello, F; Ronga, P; Beier, F; Van Cutsem, E.
Afiliação
  • Köhne CH; University Hospital of Oncology/Haematology, Oncology Center Klinikum Oldenburg gGmbH, Oldenburg, Germany. Electronic address: Onkologie@klinikum-oldenburg.de.
  • Poston G; University Hospital Aintree, Liverpool, United Kingdom.
  • Folprecht G; University Hospital Carl Gustav Carus, University Cancer Center, Dresden, Germany.
  • Ciardiello F; Seconda Università degli Studi di Napoli, Naples, Italy.
  • Ronga P; Merck KGaA, Darmstadt, Germany.
  • Beier F; Merck KGaA, Darmstadt, Germany.
  • Van Cutsem E; University Hospitals Leuven and KULeuven, Leuven, Belgium.
Eur J Surg Oncol ; 42(10): 1540-7, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27575968
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article